Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
In the most of the studies the primary endpoint is a change in HbA1c from baseline, except for the SURPASS J combo, where the primary endpoint is the number of patients with more than one critical adverse event (69, 70)
In new data from a phase 2 dose-ranging trial, researchers found weight loss continued to increase up to 13 weeks for adults with overweight or obesity
Andrew Lewis, Chief Scientific Officer at Quotient Sciences, a drug development and manufacturing accelerator that offers a range of integrated programs and tailored services to over 550 customers
Higher doses dont always mean faster results
Previous drugs have been single- or dual-agonist drugs
US$ 21.81
US$ 20.02
US$ 21.06
US$ 25.17
US$ 29.31
US$ 23.04
US$ 22.77
